Strumento inattivo

Altre lingue Aethlon Medical, Inc. OTC Bulletin Board

Azioni

AEMD

US00808Y1091

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Top Midday Decliners	15/05
Aethlon Medical Announces Pricing of $4.7 Million Public Offering	15/05
Aethlon Medical Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma	13/05
Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures	13/05
Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday	13/05
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma	10/05
Aethlon Medical, Inc. Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma	10/05
Aethlon Medical : Corporate Overview – May 2024	10/05
Aethlon Medical : Corporate Presentation April 2024	25/04
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices	21/02
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update	14/02
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024	07/02
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update	14/11
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer	13/11
Aethlon Medical, Inc Announces Executive Changes	13/11
Aethlon Medical, Inc. Announces Appointment Ofguy Ciprian as Chief Operating Officer	13/11
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023	06/11
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology	10/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aethlon Medical, Inc. OTC Bulletin Board

Azioni

AEMD

US00808Y1091

Altre lingue

Filtri